ARCHIVES

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

This article is from The Cancer Letter archive.

Vol. 04 No. 11 | March 17, 1978

Download PDF Visit The Full Archive

Related Articles

Minority Trial Participation A Matter of Access, Study Says

December 30, 2005

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

ORI Finds Misconduct By CIT Professor

August 4, 1995

Biology Societies Recomend 15% Funding Increase for NIH

February 12, 1999

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014